Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
-
Article
Open AccessParbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes
Acute myeloid leukemia (AML) is a malignancy characterized by differentiation arrest of hematopoietic precursor cells. Differentiation therapy is effective for patients with acute promyelocytic leukemia; howev...